Geode Capital Management
RPTX

Geode Capital Management’s Repare Therapeutics RPTX Stock Holding History

Geode Capital Management’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-19,128
Closed -$25.1K – 4503
2024
Q4 		$25.1K Hold
19,128
– – ﹤0.01% 4356
2024
Q3 		$65.8K Sell
19,128
-7,416
-28% -$24.4K ﹤0.01% 4204
2024
Q2 		$87.6K Hold
26,544
– – ﹤0.01% 4170
2024
Q1 		$125K Hold
26,544
– – ﹤0.01% 4091
2023
Q4 		$194K Hold
26,544
– – ﹤0.01% 3955
2023
Q3 		$321K Sell
26,544
-5,347
-17% -$55.2K ﹤0.01% 3787
2023
Q2 		$337K Buy
31,891
+5,347
+20% +$55.1K ﹤0.01% 3800
2023
Q1 		$261K Hold
26,544
– – ﹤0.01% 3918
2022
Q4 		$390K Buy
26,544
+5,142
+24% +$76.9K ﹤0.01% 3790
2022
Q3 		$259K Hold
21,402
– – ﹤0.01% 4056
2022
Q2 		$299K Hold
21,402
– – ﹤0.01% 4028
2022
Q1 		$304K Hold
21,402
– – ﹤0.01% 4175
2021
Q4 		$451K Hold
21,402
– – ﹤0.01% 4111
2021
Q3 		$561K Hold
21,402
– – ﹤0.01% 3978
2021
Q2 		$667K Hold
21,402
– – ﹤0.01% 3799
2021
Q1 		$656K Hold
21,402
– – ﹤0.01% 3716
2020
Q4 		$734K Hold
21,402
– – ﹤0.01% 3467
2020
Q3 		$658K Hold
21,402
– – ﹤0.01% 3349
2020
Q2 		$663K Buy
+21,402
New +$687K ﹤0.01% 3276

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Geode Capital Management's RPTX Position: Q1 2025 in Review

Geode Capital Management sold out of Repare Therapeutics (RPTX) in Q1 2025, closing a stake of 19,128 shares — an estimated $25.1K sold.

Geode Capital Management first reported a position in RPTX in Q2 2020 and held it in 19 quarters. The position peaked at $734K in Q4 2020. 50 funds tracked by Wall St. Rank hold RPTX as of Q1 2025.

  • Geode Capital Management reported no remaining Repare Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Geode Capital Management sold 19,128 Repare Therapeutics shares in Q1 2025, an estimated $25.1K.
  • Geode Capital Management first reported a position in Repare Therapeutics in Q2 2020 and held it in 19 quarters.
  • Geode Capital Management's Repare Therapeutics position peaked at $734K in Q4 2020.
  • 50 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2025.

Based on Geode Capital Management's 13F filing for Q1 2025, filed 13 May 2025.